Importer of Controlled Substances Application: Scottsdale Research Institute, 17620-17621 [2023-05920]
Download as PDF
<![CDATA[
17620
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms
and Explosives
[OMB 1140–0097]
Agency Information Collection
Activities; Proposed eCollection of
eComments Requested; Supplemental
Information on Water Quality
Considerations—ATF Form 5000.30
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 60-Day notice.
AGENCY:
The Bureau of Alcohol,
Tobacco, Firearms and Explosives
(ATF), Department of Justice (DOJ), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
(IC) is also being published to obtain
comments from the public and affected
agencies.
DATES: Comments are encouraged and
will be accepted for 60 days until May
22, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
regarding the estimated public burden
or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions, or
additional information, contact: Shawn
Stevens, Explosives Industry Liaison,
Federal Explosives Licensing Center, by
mail at 244 Needy Road, Martinsburg,
WV 25427, email at FELC@atf.gov, or
telephone at 304–616–4400.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and, if so, how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of this information
collection:
1. Type of Information Collection
(check justification or form 83):
Extension without Change of a
Currently Approved Collection.
2. The Title of the Form/Collection:
Supplemental Information on Water
Quality Considerations.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): ATF
Form 5000.30.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit,
Farms.
Other (if applicable): None.
Abstract: A person engaged in the
business of manufacturing explosives is
required to have a license under the
provisions of 18 U.S.C. 843. The Federal
Water Pollution Control Act, 33 U.S.C.
1341, authorizes the execution of the
Supplemental Information on Water
Quality Considerations—ATF 5000.30,
during the application process, in order
to ensure compliance with the Act.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 680 respondents
will utilize the form annually, and it
will take each respondent
approximately 30 minutes to complete
their responses.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
340 hours, which is equal to 680 (# of
respondents) * .5 (30 minutes).
If additional information is required
contact: John Carlson, Department
Clearance Officer, Policy and Planning
Staff, Office of the Chief Information
Officer, United States Department of
Justice, Justice Management Division,
Two Constitution Square, 145 N Street
NE, Mail Stop 3.E–206, Washington, DC
20530.
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Dated: March 17, 2023.
John Carlson,
Department Clearance Officer, Policy and
Planning Staff, U.S. Department of Justice.
[FR Doc. 2023–05926 Filed 3–22–23; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1161]
Importer of Controlled Substances
Application: Scottsdale Research
Institute
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Scottsdale Research Institute
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUMMARY:
E:\FR\FM\23MRN1.SGM
23MRN1
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 12, 2023,
Scottsdale Research Institute, 12815
North Cave Creek Road, Phoenix,
Arizona 85022, applied to be registered
as an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7350
7360
7370
7437
7438
I
I
I
I
I
The company plans to import
Marihuana Extract (7350), Marihuana
(7360), and Tetrahydrocannabinols
(7370) as flowering plants to support
analytical purposes, research, and the
manufacturing of dosage forms for
clinical trials. This notice does not
constitute an evaluation or
determination of the merits of the
company’s application. The company
plans to import fungi material from
which Psilocybin (7437) and Psilocyn
(7438) will be produced for further
manufacturing prior to use in research
and clinical trials. No other activities for
these drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05920 Filed 3–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug
code
Controlled substance
Drug Enforcement Administration
Psilocybin ......................
Importer of Controlled Substances
Application: Lonza Tampa, LLC
The company plans to import drug
code 7437 (Psilocybin) as finished
dosage for clinical trials, research, and
analytical purposes. No other activity
for this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Lonza Tampa, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
SUMMARY:
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00106
Fmt 4703
7437
Schedule
[Docket No. DEA–1170]
AGENCY:
ddrumheller on DSK120RN23PROD with NOTICES1
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 10, 2023,
Lonza Tampa, LLC, 4901 West Grace
Street, Tampa, Florida 33607–3805,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DATES:
Sfmt 4703
I
17621
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05940 Filed 3–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1168]
Importer of Controlled Substances
Application: Caligor Coghlan Pharma
Services
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Caligor Coghlan Pharma
Services has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
SUMMARY:
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17620-17621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05920]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1161]
Importer of Controlled Substances Application: Scottsdale
Research Institute
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Scottsdale Research Institute has applied to be registered as
an importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 24, 2023. Such persons may also file a written request for a
hearing on the application on or before April 24, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
[[Page 17621]]
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on January 12, 2023, Scottsdale Research Institute,
12815 North Cave Creek Road, Phoenix, Arizona 85022, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
------------------------------------------------------------------------
The company plans to import Marihuana Extract (7350), Marihuana
(7360), and Tetrahydrocannabinols (7370) as flowering plants to support
analytical purposes, research, and the manufacturing of dosage forms
for clinical trials. This notice does not constitute an evaluation or
determination of the merits of the company's application. The company
plans to import fungi material from which Psilocybin (7437) and
Psilocyn (7438) will be produced for further manufacturing prior to use
in research and clinical trials. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05920 Filed 3-22-23; 8:45 am]
BILLING CODE P
